These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 9165283

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of followup, does it work?
    Kaplan SA, Olsson CA, Te AE.
    J Urol; 1996 Jun; 155(6):1971-4. PubMed ID: 8618299
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry.
    Wei JT, Miner MM, Steers WD, Rosen RC, Seftel AD, Pasta DJ, Carman WJ, Roehrborn CG, BPH Registry Steering Committee.
    J Urol; 2011 Sep; 186(3):971-6. PubMed ID: 21791352
    [Abstract] [Full Text] [Related]

  • 5. Practice patterns regarding prostate cancer and benign prostatic hyperplasia in Japanese primary care practitioners.
    Fukagai T, Maruyama K, Nagata M, Morita M, Naoe M, Yoshida H.
    Int J Urol; 2007 May; 14(5):412-5. PubMed ID: 17511723
    [Abstract] [Full Text] [Related]

  • 6. Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications.
    Seftel A, Rosen R, Kuritzky L.
    Int J Impot Res; 2007 May; 19(4):386-92. PubMed ID: 17377613
    [Abstract] [Full Text] [Related]

  • 7. [Who works in the prevention and early detection of benign prostatic hyperplasia and prostate cancer in Croatia?].
    Kranjcević K, Marković BB.
    Acta Med Croatica; 2007 Feb; 61(1):45-8. PubMed ID: 17593640
    [Abstract] [Full Text] [Related]

  • 8. Differences in initial benign prostatic hyperplasia management between primary care physicians and urologists.
    Hollingsworth JM, Hollenbeck BK, Daignault S, Kim SP, Wei JT.
    J Urol; 2009 Nov; 182(5):2410-4. PubMed ID: 19765742
    [Abstract] [Full Text] [Related]

  • 9. The American Urological Association 2003 guideline on management of benign prostatic hyperplasia: a Canadian opinion.
    Nickel JC, Saad F.
    Can J Urol; 2004 Apr; 11(2):2186-93. PubMed ID: 15182407
    [Abstract] [Full Text] [Related]

  • 10. Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries.
    Fourcade RO, Théret N, Taïeb C, BPH USAGE Study Group.
    BJU Int; 2008 May; 101(9):1111-8. PubMed ID: 18279447
    [Abstract] [Full Text] [Related]

  • 11. [Benign prostatic hyperplasia; recommendations for transmural care. Working Group, Dutch College of General Practitioners and Netherlands College of Urologists].
    Klomp ML, Rosmalen CF, Romeijnders AC, Oosterhof GO, Schlatmann TJ.
    Ned Tijdschr Geneeskd; 1998 Nov 21; 142(47):2563-8. PubMed ID: 10028352
    [Abstract] [Full Text] [Related]

  • 12. Screening for prostate cancer: a comparison of urologists and primary care physicians.
    McKnight JT, Tietze PH, Adcock BB, Maxwell AJ, Smith WO, Nagy MC.
    South Med J; 1996 Sep 21; 89(9):885-8. PubMed ID: 8790311
    [Abstract] [Full Text] [Related]

  • 13. [The urologist and prostatic disease. National survey. Members of the Spanish Council of Prostatic Health].
    Jiménez Cruz JF, Rodríguez Vallejo JM, Conejero J, Resel L, Rioja Sanz LA, Vela Navarrete R, Vicente J.
    Actas Urol Esp; 1996 Sep 21; 20(7):630-5. PubMed ID: 8975548
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Factors influencing use of the prostate-specific antigen screening test in primary care.
    Moran WP, Cohen SJ, Preisser JS, Wofford JL, Shelton BJ, McClatchey MW.
    Am J Manag Care; 2000 Mar 21; 6(3):315-24. PubMed ID: 10977432
    [Abstract] [Full Text] [Related]

  • 18. Patterns in the diagnosis and management of benign prostatic hyperplasia in a country that does not have country-specific clinical practice guidelines.
    Paick JS, Kim SW, Ku JH.
    Yonsei Med J; 2007 Apr 30; 48(2):281-8. PubMed ID: 17461528
    [Abstract] [Full Text] [Related]

  • 19. Benign prostatic hyperplasia and prostate cancer: an overview for primary care physicians.
    Sausville J, Naslund M.
    Int J Clin Pract; 2010 Dec 30; 64(13):1740-5. PubMed ID: 21070524
    [Abstract] [Full Text] [Related]

  • 20. The benign prostatic hyperplasia registry and patient survey: study design, methods and patient baseline characteristics.
    Roehrborn CG, Nuckolls JG, Wei JT, Steers W, BPH Registry and Patient Survey Steering Committee.
    BJU Int; 2007 Oct 30; 100(4):813-9. PubMed ID: 17822462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.